VTR - Ventas, Inc.

NYSE - NYSE Delayed Price. Currency in USD
59.03
+0.74 (+1.27%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close58.29
Open58.28
Bid58.67 x 900
Ask59.41 x 1300
Day's Range58.04 - 59.32
52 Week Range46.55 - 65.70
Volume1,546,619
Avg. Volume2,010,232
Market Cap21.271B
Beta (3Y Monthly)0.38
PE Ratio (TTM)51.78
EPS (TTM)1.14
Earnings DateApr 26, 2019
Forward Dividend & Yield3.17 (4.97%)
Ex-Dividend Date2019-03-29
1y Target Est61.38
Trade prices are not sourced from all markets
  • Why SL Green Realty (SLG) Might Surprise in Q1 Earnings
    Zacks5 days ago

    Why SL Green Realty (SLG) Might Surprise in Q1 Earnings

    Leveraging on favorable office real estate trends, SL Green Realty (SLG) enters into lease agreements, as well as announces redevelopment projects in Q1.

  • What's in the Cards for Crown Castle (CCI) in Q1 Earnings?
    Zacks5 days ago

    What's in the Cards for Crown Castle (CCI) in Q1 Earnings?

    Though Crown Castle International's (CCI) site-rental revenues are expected to witness continued growth amid robust tailwinds, consolidation in the wireless industry remains a concern.

  • Business Wire9 days ago

    Ventas Chairman and CEO, Debra A. Cafaro, Named Chair of The Economic Club of Chicago

    Debra A. Cafaro, Ventas, Inc. (VTR) Chairman and Chief Executive Officer, has been selected as chair of the board of directors of The Economic Club of Chicago for a two-year term beginning July 1, 2019. The appointment was announced during the Club’s 91st Annual Dinner Meeting on April 10, 2019, where Cafaro was the guest speaker. “The Economic Club of Chicago is a historic and highly relevant organization that sparks dialogue on important topics and serves as a positive force in our city, and I am honored to carry on that proud legacy as its new Chair,” said Cafaro.

  • Should You Hold Ventas (VTR) Stock in Your Portfolio Now?
    Zacks11 days ago

    Should You Hold Ventas (VTR) Stock in Your Portfolio Now?

    While Ventas' (VTR) investments in medical office and life-science real estate portfolio seem apt given the rise in ageing demography, escalating supply of senior housing assets is a concern.

  • Is Ventas, Inc. (NYSE:VTR) A Healthy REIT?
    Simply Wall St.13 days ago

    Is Ventas, Inc. (NYSE:VTR) A Healthy REIT?

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Ventas, Inc. is a US$23b large-cap, real estate investment trust (REIT) based in Chicago, United States. REI...

  • Healthcare Realty Completes MOB Buyouts in Potential Markets
    Zacks15 days ago

    Healthcare Realty Completes MOB Buyouts in Potential Markets

    Healthcare Realty (HR) completes purchase of four properties, amid soaring popularity for medical-office buildings.

  • 6 Stocks Vulnerable To 20% Plunges Amid The Bull Rebound
    Investopedia17 days ago

    6 Stocks Vulnerable To 20% Plunges Amid The Bull Rebound

    The stock market's robust 14.7% gain thus far in 2019, as measured by the S&P 500 Index (SPX) at today's open, has lifted a large number of stocks, and many investors forecast more gains as the economy strengthens. Goldman Sachs says, "real GDP growth will rebound to 3.0% in 2Q from the 0.7% pace in 1Q that encompasses the 34-day federal government shutdown," according to the firm's latest US Weekly Kickstart report. Goldman's latest US Quarterly Chartbook report identifies 40 stocks that their analysts expect to fall significantly, with these six topping the list with declines of nearly 20% or more: Juniper Networks Inc. (JNPR), Church & Dwight Co. Inc. (CHD), Clorox Co. (CLX), Realty Income Corp. (O), Ventas Inc. (VTR), and The Hershey Co. (HSY).

  • Business Wire19 days ago

    Ventas Announces First Quarter 2019 Earnings Release Date and Conference Call

    Ventas, Inc. (VTR) will issue its first quarter 2019 earnings release prior to the opening of trading on the New York Stock Exchange on Friday, April 26, 2019. The dial-in number for the conference call is (844) 776-7841 (or +1 (661) 378-9542 for international callers), and the participant passcode is “Ventas.” The call will also be webcast live by NASDAQ OMX and can be accessed at the Company’s website at www.ventasreit.com. A replay of the call will be available at the Company’s website, or by calling (855) 859-2056 (or +1 (404) 537-3406 for international callers), passcode 7352119, beginning on April 26, 2019, at approximately 1:00 p.m. Eastern Time and will remain available for 36 days.

  • Were Hedge Funds Right About Dumping Ventas, Inc. (VTR)?
    Insider Monkey22 days ago

    Were Hedge Funds Right About Dumping Ventas, Inc. (VTR)?

    "Market conditions are changing. The continued rise in interest rates suggests we are in the early stages of a bond bear market, which could intensify as central banks withdraw liquidity. The receding tide of liquidity will start to reveal more rocks beyond what has been exposed in emerging markets so far, and the value of […]

  • 6 Must-See Stock Trades for Friday: AAPL, QRVO, GES, SQ, EA
    InvestorPlacelast month

    6 Must-See Stock Trades for Friday: AAPL, QRVO, GES, SQ, EA

    Stocks were rocking and rolling on Thursday, with all three major U.S. indices putting up big gains on the day. After Wednesday's Fed news, that's no surprise. Let's get a look at some of today's big movers with our must-see stock trades. Must-See Stock Trades 1: AppleEarlier this month we outlined the long trade in Apple (NASDAQ:AAPL). Then earlier this week, we said investors should consider locking in some profits after the stock's monster move. Now AAPL is erupting more than 4% on Thursday as the longs keep on cashing in.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 5 Stocks To Buy for the Happiest Employees $200 becomes an obvious magnet, even as its RSI and MACD (green circles) continue into extended territory. This setup does not favor new long positions, but the recent strength does give us a solid buy-the-dips setup going forward.If you're still long, consider trailing up those stops and locking in some gains. Must-See Stock Trades 2: GuessGuess? (NYSE:GES) picked a pretty interesting time to report earnings, with the worse-than-expected results coming on the evening before Levi (NYSE:LEVI) went public.The latter is up more than 30% on the day as investors gobble up the new IPO. On the plus side, GES stock is clinging to range support near $19. This level has been vital over the past 12 months.There are better buys out there than GES, but investors who feel compelled to go long can use Thursday's low as their stop-loss. Must-See Stock Trades 3: VentasVentas (NYSE:VTR) isn't necessarily the top stock to focus on, but its price action gives us opportunity. On Wednesday we talked about how the Fed gave bulls the green light, saying it's essentially on hold this year when it comes to rate hikes. Well, that bodes incredibly well for dividend stocks and REITs.There's a reason why names like AT&T (NYSE:T), VTR, Realty Income (NYSE:O), Digital Realty (NYSE:DLR) and others are surging on the day. Look to see if these names can give us some follow through on Friday and into next week. (Here's the setup on AT&T).For VTR specifically, it held uptrend support and is back over the 20-day and 50-day moving averages. Look to see if it can get to and breakout over $65. Must-See Stock Trades 4: QorvoShares of Qorvo (NASDAQ:QRVO) erupted more than 7% on Thursday thanks to an upgrade from Goldman Sachs. But an earnings beat from Micron (NASDAQ:MU) and continued strong price action from Advanced Micro Devices (NASDAQ:AMD) (trade layout here) and Nvidia (NASDAQ:NVDA) (trade layout here) certainly helps.The move up through $74 is significant. Not only has this level played a notable role in the past, but it's the 61.8% Fibonacci retracement for the 52-week range. Maintaining this level paves the way to $78. Should QRVO fail to hold this level, it would be encouraging to see it hold the 200-day as support.Bulls shouldn't let Qorvo get below the 20-day and uptrend support. There's still room to rally according to the MACD and RSI, despite Thursday's big move. Must-See Stock Trades 5: SquareTrending higher and peeking through resistance is Square (NYSE:SQ). The move puts SQ over the 20-day moving average and if it can close over $78, it opens up the possibility of a move to $82.50.This name tends to be volatile, but over the 200-day and SQ stock is fine. Admittedly that's a wide range from current levels but the RSI and MACD still leave plenty of room for the stock to rally. Must-See Stock Trades 6: Electronic ArtsLet's do one more really quick with Electronic Arts (NASDAQ:EA). * 10 Stocks on the Rise Heading Into the Second Quarter Up 7.5% on the day and it's breaking out of its recent range in a big way. I want to see EA stay over $100 now. My upside target is $108.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell is long AAPL, VTR, O, DLR and SQ. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Specialty Retail ETFs to Buy the Industry's Disruption * 5 Stocks To Buy for the Happiest Employees * 3 Out-of-Favor Consumer Stocks to Buy Compare Brokers The post 6 Must-See Stock Trades for Friday: AAPL, QRVO, GES, SQ, EA appeared first on InvestorPlace.

  • InvestorPlacelast month

    Invest in America’s Rising Healthcare Costs With These Stocks

    Not a day goes by that healthcare costs aren't being discussed across each corner of media. With the 2020 election now underway, politicos are ratcheting up the rhetoric over healthcare costs and the political ads are already spinning the topic. And all of this is for good reason. Healthcare costs in the U.S. are high and rapidly rising, especially if you're of retirement age. According to the U.S. Centers for Medicare and Medicaid Services (CMS) -- healthcare spending increased in 2017 by 3.90% to $3.9 trillion or $10,739 per person. This represents 17.90% of the then gross domestic product of the U.S. (GDP). In fact, in a recently published book, More than Medicine: The Broken Promise of American Health by Bob Kaplan, he argues that the U.S. pays way more than its mature economic peers.For example, the U.S. pays 18% of its gross domestic product (GDP) on healthcare whereas the European Union (E.U.) only pays 10% of its combined GDP. And, to make it worse, the U.S. has a lower life expectancy than many nations around the globe. Add in a high poverty rate, which can lead to further health challenges for young and old and other factors showing health troubles, including infant mortality, and the nation doesn't look too healthy. American healthcare may well get even more expensive, as the U.S. ages and becomes less healthy by the day. This isn't a good mix for one of the leading economies of the planet.In a recent study by the U.S. Department of Commerce and the U.S. Census, by 2035, it is projected that 78 million folks will be 65 years or older. That same year, those at or under the age of 18 years will number just 76 million. America is becoming a nation of the elderly -- a significant change in the demographics of a nation traditionally known for its healthy and able folks. It's a shift that leaves many wondering where our economic productivity gains will come from. And, as we know, the elderly population requires the most attentive healthcare … no wonder healthcare spending is climbing.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks on the Rise Heading Into the Second Quarter While this sounds bleak, there is a silver lining here for us as investors. And no, I'm not suggesting that we look at gym companies (although I am poking around at that market with some innovations that I'll be writing about in Profitable Investing in the near future). Rather, I'm suggesting that investing in healthcare stocks that pay dividends is a smart source for capital gains … WP Carey Click to Enlarge Source: Bloomberg One healthcare stock, in particular, comes to mind … I'm referring to WP Carey (NYSE:WPC), which I've written about extensively for InvestorPlace.WP Carey is a REIT, which since coming to the public market, has generated a return of 1,348.28% for an average annual equivalent return of 13.46%. That's not too shabby any way you cut it. The business itself is a curious one: WP Carey doesn't operate its properties, and it doesn't pay for maintenance, insurance, or taxes. Instead, it executes "triple net leases." This means that it locks up long-term cashflows with less risk in rising costs for the properties and the vagrancies of tax rates.Its tenants pay for all of that, thus WP Carey profits from other peoples' money.In the healthcare market, there is a specific equivalent in the following security. Well, this next security is technically a real estate investment trust (REIT) that owns and acquires healthcare facilities including inpatient and outpatient facilities as well as surgical centers and specialty healthcare facilities. Their properties amount to more than 120 properties in 25 states as well as some newer innovative investments in Germany. Scroll down to discover what it is … Medical Properties Trust (MPW) Click to Enlarge Source: Bloomberg Medical Properties Trust (NYSE:MPW) has properties that are leased on a net basis to operators that run the facilities and pay rent month after month for years. The portfolio has expanded dramatically over the recent year with only a small pause in the past year. But it continues to look to expand its portfolio with the right properties in an ever-expanding market.Revenues are climbing with gains running at over 11.30% in just the trailing year. And the funds from operations (FFO) which measures just the return rate from the cashflows from the property portfolio is ample at 11.60%, which is impressive for the REIT space. This contributes to an impressive return on its assets at 11.40% and is what delivers for shareholders with a return on equity of 24.30%.And the stock continues to reflect its performance as a company. Over the past ten years, the stock has delivered a total return of 994.12% for an average annual equivalent of 26.79%. It is a disciplined company when it comes to debt and leverage as its debt to capital is at only 47.00%. This provides the ability to easily service its current debts and provides eased access for credit to fund additional acquisitions. Valued at only 1.49 times its book value, MPW is a steal from a price-book (P/B) perspective. This ratio has climbed significantly over the trailing year, from 1.14 times back in October 2018.But it isn't just the P/B ratio that's rising, but the actual value of the assets. Over the past five years alone, the underlying book value per share has gone from $7.98 to a current $12.27, which represents an impressive gain of 53.76%. This is important as it shows genuine growth in the underlying company and not just the stock price. The dividend is currently at 25 cents per share and has been climbing in distribution by an average annual rate of 4.30% over the past five years. This equates to a current yield of 5.48%. * Top 7 Service Sector Stocks That Will Pay You to Own Them Medical Properties Trust makes for a great buy in the healthcare market (which should be purchased in a taxable account). This is due to the Tax Cuts and Jobs Act (TCJA) which provides a tax deduction of 20% of the dividend distribution for U.S. individual investors making the taxable equivalent yield even higher. Other Stocks to Play HealthcareInside the Profitable Investing model portfolios, I have the overall market for healthcare synthetically invested in the Vanguard Healthcare ETF (NYSEARCA:VHT), which remains a buy in a tax-free account. Then, in my Incredible Dividend Machine portfolio inside Profitable Investing, I have three more plays on healthcare …I have the drugmaker Merck (NYSE:MRK), which continues to perform for shareholders. And I have another drugmaker in Pfizer (NYSE:PFE), which follows the success of Merck. Further, I also have Ventas (NYSE:VTR), which as a real estate investment trust (REIT) that owns a series of senior healthcare and related housing care facilities. VTR is doing quite well with the general REIT sector as we move further into 2019.One of the smartest investment lessons that I learned, from one of my best stocks within Profitable Investing, is to capitalize when the opportunity arises. That is, take risks while you lock in revenues! And the aforementioned stocks should continue to position themselves into the thick of the rising healthcare spending market while paying out an ample and rising dividend.Neil George is the editor of Profitable Investing and does not have any holdings in the securities mentioned above. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Invincible Stocks Leading The Bull Market Higher * 5 Dow Jones Stocks Coming to Life * 7 of the Best High-Yield Funds for 2019 and Beyond Compare Brokers The post Invest in America's Rising Healthcare Costs With These Stocks appeared first on InvestorPlace.

  • 3 Dividend Stocks Perfect for Retirees
    Motley Foollast month

    3 Dividend Stocks Perfect for Retirees

    Here's why these high-income stocks can be owned in retirement portfolios.

  • Healthcare Realty (HR) Prices Offering of 3.25M Common Stock
    Zackslast month

    Healthcare Realty (HR) Prices Offering of 3.25M Common Stock

    Healthcare Realty's (HR) latest public offering of common stock will improve its financial flexibility and provide ample scope for deploying capital in accretive acquisitions.

  • InvestorPlacelast month

    7 ETFs to Buy to Ride the Longevity Economy

    Do you ever watch the Today Show? It frequently runs a segment where it celebrates the birthdays of people who are 100 years or older. As we are living longer, the number of celebrations has grown exponentially since Willard Scott started the practice in 1983. The economic effects of this demographic shift are tangible. InvestorPlace - Stock Market News, Stock Advice & Trading TipsSo, when I saw a recent article in Builder magazine that asked the question of what happens when more people live to 100 -- and more importantly, live to be a centenarian in relatively good health, there's money to made by investors. "The impact of what's known as the "longevity economy" -- defined as the purchasing power of those 55 and older -- is over $7.6 trillion in the United States alone," stated Builder contributor John McManus. "Many business leaders are recognizing that there are, and will continue to be, financial reasons to pay attention to these demographic shifts."While you could probably come up with a few names of companies that will benefit from an aging population, to save you some time, I thought I'd give you the answer on a silver platter with a few worth-while exchange-traded funds to consider. * The 10 Best Stocks to Buy for the Bull Market's Anniversary Here are seven ETFs to buy to ride the longevity economy. The Long-Term Care ETF (OLD)The meaning of the name behind the The Long-Term Care ETF (NASDAQ:OLD) is reasonably self-explanatory. OLD is an ETF from Janus Henderson (NYSE:JHG) that seeks to invest in companies around the world that are providing long-term care to an aging population. Tracking the Solactive Long-Term Care Index, OLD is a portfolio of 46 stocks that work in and around long-term care. The top ten holdings account for 68% of the fund's $16.5 million in total assets.Almost three years old, OLD's track record is still relatively short. However, over the past year, it did achieve an annual total return of 22.9% through Mar. 12; ten times the return of the S&P 500 over the same period.Charging 0.35% in expenses (or $35 annually per $10,000 invested), it has a nice mix of large and small companies, which means you're going to get a combination of large-cap dividend payers along with small- and mid-cap growth stocks. Oh, and don't forget, it benefits from an aging population. Global X Longevity Thematic ETF (LNGR)If you're going to invest in ETFs benefiting from the longevity economy, there is no more appropriate an investment than the Global X Longevity Thematic ETF (NASDAQ:LNGR), which tracks the Indxx Global Longevity Thematic Index. The index focuses on four longevity themes: Health care products, health care services, medical devices and senior homes. Within those four themes are 19 related industries. A company must generate at least 50% of its revenue from one of the four themes to qualify for inclusion. These are considered pure-play longevity companies. The index's goal is to assemble a portfolio of 100 companies. No stock can account for more than a 3% weight cap and a 0.3% weight floor. No industry can account for more than 60% of the portfolio. It's reconstituted and rebalanced annually in April. In existence since May 2016, LNGR has managed to attract $17.1 million in assets under management, which isn't much, but given how competitive the ETF space is, it's better than many other niche funds. * 10 Dividend Stock Winners Charging 0.50% annually, ETF specialists would probably call it expensive given almost 70% of the portfolio is invested in two industries -- healthcare equipment and biotechnology, which you can get elsewhere for less. iShares Residential Real Estate Capped ETF (REZ) While the iShares Residential Real Estate Capped ETF (NYSEARCA:REZ) is a play on real estate, two of the fund's top ten holdings are Ventas (NYSE:VTR) and Welltower (NYSE:WELL), two of this country's biggest owners of healthcare real estate. REZ has 33% of its $421 million in net assets invested in healthcare REITs, making the longevity economy an important reason why this ETF should do well in the next 5-10 years. In existence since May 2007, REZ has delivered for shareholders, generating an annualized total return of 18%, 155 basis points higher than the S&P 500. As its name suggests, its primary focus is to invest in residential real estate in the U.S., which accounts for 49% of the ETFs net assets. As far as real estate ETFs go, at 0.48% annually, it's not cheap, but it has at least outperformed the index and its real estate peers. Vanguard Health Care ETF (VHT)If you're going to write an article about ETFs benefiting from the longevity economy, or any economy for that matter, you've got to include Vanguard in the mix, if only because of its lower costs. The Vanguard Health Care ETF (NYSEARCA:VHT) charges a paltry 0.10% for its portfolio of 385 healthcare stocks. Of the industries it invests in, the top four by weight are pharmaceuticals (29%), healthcare equipment (21%), biotechnology (20%) and managed healthcare (11%). VHT's top ten holdings account for 44% of the fund's $10.3 billion in total net assets making it the biggest of the seven ETFs mentioned in this article. If you're going to focus on the longevity economy, VHT makes total sense as an anchor for your entire portfolio of ETFs because it brings size, it brings low fees and it delivers performance. * 7 Inexpensive, High-Dividend ETFs to Buy A decade ago, if you invested $10,000 in VHT, today it would be worth almost $51,000. You absolutely should have this ETF in your portfolio. SPDR S&P Insurance ETF (KIE)One of the things a lot of us buy to protect our family's assets is life insurance. Unfortunately, when we think of life insurance, the first thing that comes to mind is death. And when we think of death, we think of getting old. The SPDR S&P Insurance ETF (NYSEARCA:KIE) got its start in November 2005. More than 13 years later, it has total net assets of $714 million, a reasonable amount for a sector ETF. Like a lot of these ETFs, it has a smaller number of holdings with just 48. Life and health insurers account for 28% of the portfolio, the second-largest weighting, behind property and casualty insurance at 40%. Charging a reasonable 0.35% annually, KIE tracks the S&P Insurance Select Industry Index, an index that represents the insurance segment of the S&P Total Market Index, which in addition to life and health insurance and property and casualty insurance, invests in insurance brokers, multi-line insurance companies and reinsurance companies. The index is comprised of insurance stocks that have a float-adjusted market cap of $2 billion or more. The index's modified equal weighting ensures that investors get both company diversification by type of insurance and size of the company. ARK Innovation ETF (ARKK)The ARK Innovation ETF (NASDAQ:ARKK) has quite the reputation having been named ETF of the Year in 2017. Actively managed, it focuses on companies relying on disruptive innovation to drive their growth. ARKK's largest holding is Tesla (NYSEARCA:TSLA) with a weighting of 8.4%. Perhaps you've heard of Catherine Wood, the ETF's portfolio manager? She's gained a lot of notoriety for writing a letter to Tesla CEO Elon Musk last August asking him not to take the company private. I wrote about her shortly after that letter made the rounds. With more than $1 billion in total net assets in a little over four years, Wood has done an excellent job putting ARK Investment Management on the map, the business she started in 2014 after working for others for more than 30 years. If you like ETFs that invest across all market caps, you'll like ARKK. It puts almost half of its assets in small- and mid-cap stocks, limiting its number of holdings between 35-50 of its best ideas. * 7 Dividend Stocks With Big Yields Paying 0.75% for arguably one of the best tech investors in America, this is the star of the seven ETFs to buy I've listed. Principal Millennials Index ETF (GENY)Nobody likes getting old so it stands to reason that if you're going to bet on the longevity economy, it probably makes sense to hedge your bets a little by investing in the Principal Millennials Index ETF (NASDAQ:GENY), an ETF that invests in companies that are impacted by the spending and lifestyle of people born between 1980 and the mid-2000s. While it has taken the boomers a little while to understand where the Millennials are coming from, I can assure you we boomers (I'm 54 and at the very tail end of the baby boom) recognize the economic impact that this demographic is having on companies, big and small. There's money to be made from them. The ETF tracks the Nasdaq Global Millennial Opportunity Index, a group of approximately 100 stocks that derive a significant chunk of their revenue from Millennial consumption. As a result, its holdings list is much different than the typical broad-based ETF. It charges 0.45%, That's a reasonable fee considering the three portfolio managers bring an average of 23 years of industry experience to the table, it's going to surprise a lot of investors in the future who view it merely as a fad. Expected to spend $10 trillion over their lifetime, Millennials are the real deal. And so is GENY. As of this writing, Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 15 Stocks Sitting on Huge Piles of Cash * The 10 Best Stocks to Buy for the Bull Market's Anniversary * 7 Dividend Stocks With Big Yields Compare Brokers The post 7 ETFs to Buy to Ride the Longevity Economy appeared first on InvestorPlace.

  • Markitlast month

    See what the IHS Markit Score report has to say about Ventas Inc.

    Ventas Inc NYSE:VTRView full report here! Summary * Perception of the company's creditworthiness is negative * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for VTR with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold VTR had net inflows of $4.49 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Financials sector is rising. The rate of growth is strong relative to the trend shown over the past year. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. VTR credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Ventas (VTR) Down 3.8% Since Last Earnings Report: Can It Rebound?
    Zackslast month

    Ventas (VTR) Down 3.8% Since Last Earnings Report: Can It Rebound?

    Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • GlobeNewswirelast month

    Report: Developing Opportunities within Celanese, Genuine Parts, UnitedHealth Group, Ventas, CNO Financial Group, and Multi-Color — Future Expectations, Projections Moving into 2019

    NEW YORK, March 06, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Business Wire2 months ago

    Ventas to Participate in Citi 2019 Global Property CEO Conference

    Ventas, Inc. (VTR) management will make a presentation regarding the Company at the Citi 2019 Global Property CEO Conference (the “Citi Conference”) in Hollywood, Florida on March 5, 2019 at 8:50 a.m. Eastern Time. The presentation will be audio webcast and may be accessed through the Company’s website at www.ventasreit.com/investor-relations. Any Company written materials accompanying the presentation or the Company’s meetings with certain investors at the Citi Conference will be available on the Company’s website starting at 7 a.m. Eastern Time on March 4.

  • Take these 3 steps to climate-proof your stock-market investments
    MarketWatch2 months ago

    Take these 3 steps to climate-proof your stock-market investments

    Extreme weather is on the upswing. Here’s how to mitigate the impact of climate change on your portfolio.

  • HT or VTR: Which Is the Better Value Stock Right Now?
    Zacks2 months ago

    HT or VTR: Which Is the Better Value Stock Right Now?

    HT vs. VTR: Which Stock Is the Better Value Option?

  • Mack-Cali's (CLI) Q4 FFO Meets, Revenues Miss Estimates
    Zacks2 months ago

    Mack-Cali's (CLI) Q4 FFO Meets, Revenues Miss Estimates

    Mack-Cali Realty's (CLI) fourth-quarter 2018 results indicate softness in its office portfolio. In fact, subdued leasing activity and decline in same-store cash net operating income disappoint.

  • SITE Centers (SITC) Q4 FFO Beats, Revenues Miss Estimates
    Zacks2 months ago

    SITE Centers (SITC) Q4 FFO Beats, Revenues Miss Estimates

    While SITE Centers (SITC) posts better-than-expected results, backed by healthy leasing activity, rent and same-store net operating income (NOI) growth, declining revenues remains a concern.

  • Lamar Advertising (LAMR) Q4 AFFO Tops Estimates, Revenues Up
    Zacks2 months ago

    Lamar Advertising (LAMR) Q4 AFFO Tops Estimates, Revenues Up

    Lamar Advertising (LAMR) witnesses bottom-line growth on higher revenues and solid operating income in the fourth quarter.

  • Host Hotels' (HST) Q4 FFO Beats Estimates, Revenues Up Y/Y
    Zacks2 months ago

    Host Hotels' (HST) Q4 FFO Beats Estimates, Revenues Up Y/Y

    Host Hotels & Resorts' (HST) Q4 results reflect improvements in food and beverage revenues and productivity gains. Further, year-over-year growth in comparable hotel RevPAR is encouraging.

  • Cramer's Exec Cut: A window into the world's top companies
    CNBC Videos2 months ago

    Cramer's Exec Cut: A window into the world's top companies

    Jim Cramer gets insight on how execs at Shopify, Hasbro, Twilio and more view the future of their industries.